# The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

> **NCT03498170** · PHASE1 · COMPLETED · sponsor: **Mereo BioPharma** · enrollment: 16 (actual)

## Conditions studied

- Interaction

## Interventions

- **DRUG:** BCT197
- **DRUG:** Itraconazole 200 mg

## Key facts

- **NCT ID:** NCT03498170
- **Lead sponsor:** Mereo BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-19
- **Primary completion:** 2018-05-03
- **Final completion:** 2018-05-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03498170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03498170, "The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03498170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*